Versorgungssituation von rheumakranken in Rheumatologischen Zentren im jahr 1993 = The health care situation of patients with inflammatory rheumatic diseases in specialized centres in GermanyZINK, A; LISTING, J.Das Gesundheitswesen (Stuttgart. Thieme). 1996, Vol 58, Num 12, pp 648-656, issn 0941-3790Article

Einflussfaktoren auf die Kontinuität der Basistherapie bei rheumatoider Arthritis = Reasons for discontinuation of treatment in patients with rheumatoid arthritisLISTING, J; ZINK, A; BRAUER, D et al.Zeitschrift für Rheumatologie (Print). 1998, Vol 57, Num 4, pp 246-247, issn 0340-1855Conference Paper

Was kostet die rheumatoide Arthritis den Erkrankten? Out-of-Pocket-Ausgaben im Frühstadium der Erkrankung = Out-of-pocket medical spending for care in patients with recent onset rheumatoid arthritisWESTHOFF, G; LISTING, J; ZINK, A et al.Zeitschrift für Rheumatologie (Print). 2004, Vol 63, Num 5, pp 414-424, issn 0340-1855, 11 p.Article

Open label trial of anakinra in active ankylosing spondylitis over 24 weeksHAIBEL, H; RUDWALEIT, M; LISTING, J et al.Annals of the rheumatic diseases. 2005, Vol 64, Num 2, pp 296-298, issn 0003-4967, 3 p.Article

Loss of physical independence in rheumatoid arthritis : Interview data from a representative sample of patients in rheumatologic careWESTHOFF, G; LISTING, J; ZINK, A et al.Arthritis care and research. 2000, Vol 13, Num 1, pp 11-21, issn 0893-7524Article

Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanerceptBRAUN, J; BARALIAKOS, X; LISTING, J et al.Arthritis and rheumatism. 2005, Vol 52, Num 8, pp 2447-2451, issn 0004-3591, 5 p.Article

Versorgung Rheumakranker durch Rheumatologen in einem grossstädtischen Ballungsgebiet = Specialized care of rheumatic patients in a large cityZINK, A; LISTING, J; NIEWERTH-LIEPOLD, M et al.Zeitschrift für Rheumatologie (Print). 1994, Vol 53, Num 3, pp 135-141, issn 0340-1855Conference Paper

Comparative effectiveness of tumour necrosis factor α inhibitors in combination with either methotrexate or leflunomideSTRANGFELD, A; HIERSE, F; KEKOW, J et al.Annals of the rheumatic diseases. 2009, Vol 68, Num 12, pp 1856-1862, issn 0003-4967, 7 p.Article

No efficacy of subcutaneous methotrexate in active ankylosing spondylitis : a 16-week open-label trialHAIBEL, H; BRANDT, H. C; SONG, I. H et al.Annals of the rheumatic diseases. 2007, Vol 66, Num 3, pp 419-421, issn 0003-4967, 3 p.Article

Progression of radiographic damage in patients with ankylosing spondylitis : defining the central role of syndesmophytesBARALIAKOS, X; LISTING, J; RUDWALEIT, M et al.Annals of the rheumatic diseases. 2007, Vol 66, Num 7, pp 910-915, issn 0003-4967, 6 p.Article

Messung der Lebensqualität unter Therapie mit Infliximab bei Patienten mit aktiver ankylosierender Spondylitis: Ein Vergleich von SF-36 und SF-12 = Measurement of quality of life in patients with active ankylosing spondylitis being treated with infliximab: a comparison of SF-36 and SF-12HAIBEL, H; NIEWERTH, M; BRANDT, J et al.Zeitschrift für Rheumatologie (Print). 2004, Vol 63, Num 5, pp 393-401, issn 0340-1855, 9 p.Article

Validierung einer deutschen Version des Fragebogens BASDAI zur Messung der Krankheitsaktivität bei ankylosierender Spondylitis = Adaption and validation of the bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in GermanyBRANDT, J; WESTHOFF, G; RUDWALEIT, M et al.Zeitschrift für Rheumatologie (Print). 2003, Vol 62, Num 3, pp 264-273, issn 0340-1855, 10 p.Article

The national database of the German Collaborative Arthritis Centres : I. Structure, aims, and patientsZINK, A; LISTING, J; KLINDWORTH, C et al.Annals of the rheumatic diseases. 2001, Vol 60, Num 3, pp 199-206, issn 0003-4967Article

The national database of the German Collaborative Arthritis Centres : II. Treatment of patients with rheumatoid arthritisZINK, A; LISTING, J; NIEWERTH, M et al.Annals of the rheumatic diseases. 2001, Vol 60, Num 3, pp 207-213, issn 0003-4967Article

The European Ankylosing Spondylitis Infliximab Cohort (EASIC): a European multicentre study of long-term outcomes in patients with ankylosing spondylitis treated with infliximabHELDMANN, F; BRANDT, J; SCHEWE, S et al.Clinical and experimental rheumatology (Testo stampato). 2011, Vol 29, Num 4, pp 672-680, issn 0392-856X, 9 p.Article

Inflammation in ankylosing spondylitis : a systematic description of the extent and frequency of acute spinal changes using magnetic resonance imagingBARALIAKOS, X; LANDEWE, R; BRAUN, J et al.Annals of the rheumatic diseases. 2005, Vol 64, Num 5, pp 730-734, issn 0003-4967, 5 p.Article

Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanerceptRUDWALEIT, M; BARALIAKOS, X; LISTING, J et al.Annals of the rheumatic diseases. 2005, Vol 64, Num 9, pp 1305-1310, issn 0003-4967, 6 p.Article

Treatment continuation in patients receiving biological agents or conventional DMARD therapyZINK, A; LISTING, J; HERZER, P et al.Annals of the rheumatic diseases. 2005, Vol 64, Num 9, pp 1274-1279, issn 0003-4967, 6 p.Article

Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor α blockers in ankylosing spondylitisRUDWALEIT, M; LISTING, J; BRANDT, J et al.Annals of the rheumatic diseases. 2004, Vol 63, Num 6, pp 665-670, issn 0003-4967, 6 p.Article

Impact of anti-tumour necrosis factor α treatment on admissions to hospital and days of sick leave in patients with ankylosing spondylitisLISTING, J; BRANDT, J; RUDWALEIT, M et al.Annals of the rheumatic diseases. 2004, Vol 63, Num 12, pp 1670-1672, issn 0003-4967, 3 p.Article

Häufigkeit und Verlauf juveniler Arthritiden = Frequency and evolution of juvenile chronic arthritisDÖRING, E; KIESSLING, U; MEINCKE, J et al.Zeitschrift für Rheumatologie (Print). 1998, Vol 57, Num 4, pp 255-257, issn 0340-1855Conference Paper

A Comparison of New Bone Formation in Patients With Ankylosing Spondylitis and Patients With Diffuse Idiopathic Skeletal Hyperostosis: A Retrospective Cohort Study Over Six YearsBARALIAKOS, X; LISTING, J; BUSCHMANN, J et al.Arthritis and rheumatism. 2012, Vol 64, Num 4, pp 1127-1133, issn 0004-3591, 7 p.Article

Relationship between active inflammatory lesions in the spine and sacroiliac joints and new development of chronic lesions on whole-body MRI in early axial spondyloarthritis: results of the ESTHER trial at week 48SONG, I.-H; HERMANN, K. G; HAIBEL, H et al.Annals of the rheumatic diseases. 2011, Vol 70, Num 7, pp 1257-1263, issn 0003-4967, 7 p.Article

Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor α antibody infliximabBAROLIAKOS, X; LISTING, J; RUDWALEIT, M et al.Annals of the rheumatic diseases. 2005, Vol 64, Num 10, pp 1462-1466, issn 0003-4967, 5 p.Article

Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximabSIEPER, J; BARALIAKOS, X; LISTING, J et al.Rheumatology (Oxford. Print). 2005, Vol 44, Num 12, pp 1525-1530, issn 1462-0324, 6 p.Article